Vaccine-preventable diseases or their complications account for 50,000 to 90,000 adult deaths in the U.S. each year.
Approximately 1.7 million Americans develop hospital-acquired HAIs each year.
Atrial fibrillation is the most common heart arrhythmia in the U.S. Often going undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans.
At age 60, 1 in 25 Americans have AFib. At age 80+, this increases to nearly 1 in 10.
As our population continues to age, prevalence of Afib is going to skyrocket, to a projected 5.6 to 15.9 million adults by 2050.
Projected increases in the prevalence of Afib
AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study estimates that Medicare alone pays $15.7 billion per year to treat newly diagnosed AFib patients.
The risk of having a stroke increases 5-fold in individuals with AFib. Individuals with AFib also have more severe and recurrent strokes than those without the disease.
Distribution of inpatient and selected outpatient costs for treating AFib.
Stroke is very disabling and individuals recovering from a stroke who also have AFib have a higher risk of remaining disable or handicapped compared to stroke patients without AFib.
AFib can also lead to heart failure. Within the first year of diagnosis, AFib patients have a 36.7% chance of experiencing heart failure– compared to 10.4% in those without AFib.
Individuals with AFib have a twice the risk of dementia.
Alliance for Aging Research launches new version of The Silver Book® site that offers a modern design, intuitive navigation, and a content-rich experience. With an emphasis on visualization of data, such…